1.Research progress of hybrid coronary revascularization in treating coronary atherosclerotic heart disease
Xiaoyu ZHANG ; Yuanyuan PAN ; Minghuan FU ; Yun LIN ; Yiran CHEN ; Yu PENG
The Journal of Practical Medicine 2025;41(6):916-920
The incidence rate of coronary atherosclerotic heart disease(commonly referred to as coronary heart disease)remains high in China.In clinical practice,drug therapy,percutaneous coronary intervention(PCI),and coronary artery bypass grafting(CABG)are commonly employed.For patients with multi-vessel coronary artery stenosis,minimally invasive interventional therapy is often the preferred option.However,for those with multi-vessel disease complicated by comorbidities,CABG is generally recommended.Despite its advantages,PCI carries risks such as vascular restenosis,thrombosis,and other adverse events.Consequently,hybrid coronary revascularization(HCR)has emerged as an alternative approach.This paper provides an overview of coronary heart disease and re-views the advantages,applications,and patient selection criteria for HCR.
2.Research progress of hybrid coronary revascularization in treating coronary atherosclerotic heart disease
Xiaoyu ZHANG ; Yuanyuan PAN ; Minghuan FU ; Yun LIN ; Yiran CHEN ; Yu PENG
The Journal of Practical Medicine 2025;41(6):916-920
The incidence rate of coronary atherosclerotic heart disease(commonly referred to as coronary heart disease)remains high in China.In clinical practice,drug therapy,percutaneous coronary intervention(PCI),and coronary artery bypass grafting(CABG)are commonly employed.For patients with multi-vessel coronary artery stenosis,minimally invasive interventional therapy is often the preferred option.However,for those with multi-vessel disease complicated by comorbidities,CABG is generally recommended.Despite its advantages,PCI carries risks such as vascular restenosis,thrombosis,and other adverse events.Consequently,hybrid coronary revascularization(HCR)has emerged as an alternative approach.This paper provides an overview of coronary heart disease and re-views the advantages,applications,and patient selection criteria for HCR.
3.Relationship of monocyte to HDL-C ratio and thromboxane B2 with LAAT of elderly patients with atrial fibrillation
Yuanyuan PAN ; Biao CHENG ; Xuefei TAO ; Xiaohan CHEN ; Jie GAO ; Minghuan FU
Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2025;27(1):18-21
Objective To observe the association of the changes in monocyte to high density lipo-protein cholesterol ratio(MHR)and thromboxane B2(TXB2)with risk of left atrial appendage thrombus(LAAT)in elderly patients with atrial fibrillation(AF).Methods A retrospective study was conducted on 152 elderly AF patients admitted in our hospital from May 2022 to May 2024.According to the results of transesophageal echocardiography,they were divided into thrombus group(46 cases)and non-thrombus group(106 cases).Blood MHR and TXB2 levels were measured and calculated,and the predictive efficacy of MHR and TXB2 levels for the risk of LAAT was analyzed.Results The thrombus group had older age,larger left atrial diameter(LAD),higher monocyte count,and larger proportion of persistent AF(P<0.01),while lower LVEF and HDL-C levels when compared with the non-thrombus group(P<0.05,P<0.01).The MHR and TXB2 level were significantly higher in the thrombus group than those in non-thrombus group(P<0.01).Multivariate logistic regression analysis indicated that age(OR=1.244,95%CI:1.022-1.466,P=0.028),persistent AF(OR=29.290,95%CI:4.573-187.610,P=0.000),LAD(OR=1.502,95%CI:1.203-1.876,P=0.000),MHR(OR=1.115,95%CI:1.055-1.178,P=0.000)and TXB2(OR=1.064,95%CI:1.031-1.097,P=0.000)were risk fac-tors for LAAT in elderly AF patients,and LVEF(OR=0.813,95%CI:0.707-0.935,P=0.004)was a protective factor.ROC curve analysis suggested that the AUC value of MHR and TXB2 in evaluating the risk of LAAT in elderly AF patients was 0.767 and 0.829,respectively.Conclusion MHR and TXB2 are abnormally elevated in elderly AF patients with LAAT.They are risk factors affecting the occurrence of LAAT,and have certain predictive value for the risk of LAAT.
4.Relationship of monocyte to HDL-C ratio and thromboxane B2 with LAAT of elderly patients with atrial fibrillation
Yuanyuan PAN ; Biao CHENG ; Xuefei TAO ; Xiaohan CHEN ; Jie GAO ; Minghuan FU
Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2025;27(1):18-21
Objective To observe the association of the changes in monocyte to high density lipo-protein cholesterol ratio(MHR)and thromboxane B2(TXB2)with risk of left atrial appendage thrombus(LAAT)in elderly patients with atrial fibrillation(AF).Methods A retrospective study was conducted on 152 elderly AF patients admitted in our hospital from May 2022 to May 2024.According to the results of transesophageal echocardiography,they were divided into thrombus group(46 cases)and non-thrombus group(106 cases).Blood MHR and TXB2 levels were measured and calculated,and the predictive efficacy of MHR and TXB2 levels for the risk of LAAT was analyzed.Results The thrombus group had older age,larger left atrial diameter(LAD),higher monocyte count,and larger proportion of persistent AF(P<0.01),while lower LVEF and HDL-C levels when compared with the non-thrombus group(P<0.05,P<0.01).The MHR and TXB2 level were significantly higher in the thrombus group than those in non-thrombus group(P<0.01).Multivariate logistic regression analysis indicated that age(OR=1.244,95%CI:1.022-1.466,P=0.028),persistent AF(OR=29.290,95%CI:4.573-187.610,P=0.000),LAD(OR=1.502,95%CI:1.203-1.876,P=0.000),MHR(OR=1.115,95%CI:1.055-1.178,P=0.000)and TXB2(OR=1.064,95%CI:1.031-1.097,P=0.000)were risk fac-tors for LAAT in elderly AF patients,and LVEF(OR=0.813,95%CI:0.707-0.935,P=0.004)was a protective factor.ROC curve analysis suggested that the AUC value of MHR and TXB2 in evaluating the risk of LAAT in elderly AF patients was 0.767 and 0.829,respectively.Conclusion MHR and TXB2 are abnormally elevated in elderly AF patients with LAAT.They are risk factors affecting the occurrence of LAAT,and have certain predictive value for the risk of LAAT.
5.Influencing factors for unplanned re-hospitalization in adult renal transplant recipients after surgery
Weiwei CAO ; Minghuan ZHONG ; Zhou SUN ; Guofu LIANG ; Fu YAN ; Chao LIU ; Li MA ; Kejing ZHU ; Yanyan XU ; Bei DING ; Yulin NIU
Journal of Clinical Medicine in Practice 2024;28(18):117-122
Objective To investigate the influencing factors of unplanned rehospitalization within one year after surgery among adult renal transplant recipients. Methods The clinical data of 299 recipients who underwent renal transplant surgery in the Department of Organ Transplantation of the Affiliated Hospital of Guizhou Medical University from January 2020 to December 2022 were retrospectively analyzed. The recipients were divided into unplanned rehospitalization group and non-rehospitalization group based on whether they experienced unplanned rehospitalization within one year after surgery. Univariate analysis and binary Logistic regression analysis were performed to explore the influencing factors of unplanned rehospitalization within one year after renal transplantation. Results Among the 299 recipients, 102 experienced unplanned rehospitalization, with an incidence rate of 34.11%. Univariate analysis revealedstatistically significant differences were noted between the two groups in terms of gender, occupational status, preoperative underlying disease, rejection reactions, nosocomial infections, immunosuppressive medication regimens, serum creatinine, cystatin C, serum phosphorus, serum potassium, and initial hospitalization duration (


Result Analysis
Print
Save
E-mail